Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

British Medical Journal Report Supports SCHS White Paper On Statins
The results of a study published in the current issue of the peer reviewed British Medical Journal (BMJ) support the findings of a white paper released last month by the Senior Center for Health and Security (SCHS) regarding the potentially lifesaving qualities of cholesterol lowering drugs known as statins.
generic viagra online
Massachusetts, Tennessee Health Plans Might Offer Ideas On U.S. Health Care System Overhaul
Congressional lawmakers who are crafting a plan to overhaul the U.S. health care system might be able to look to state health insurance programs in Massachusetts and Tennessee for ideas, the AP/Minneapolis Star Tribune reports. Health reform legislation modeled after Massachusetts" near-universal health insurance law "is likely to emerge" in Congress, "although details remain unsettled," the AP/Star Tribune reports. The plan also could include components of Tennessee"s CoverTN program, which charges beneficiaries who smoke or are overweight higher premiums. Lawmakers in the Senate already have discussed a lifestyle tax funding mechanism, such as taxes on alcohol and sugary beverages. According to AP/Star Tribune, Massachusetts "chose to cover virtually everyone," while Tennessee "chose to get just a few more people bare-bones insurance at a budget price with limits on how much plans would pay for hospital stays."Alan Weil of the National Academy for State Health Policy said, "The belief that we should all have health insurance coverage is broadly held," but "there are tremendous differences around the country in beliefs on how to achieve that goal." He added, "We learn from Massachusetts that a bold objective matters. If it can be sustained, that"s terrific," and "[i]t would be nice if you had a southern state that had achieved universal coverage and did it in a different way, but we don"t have that" (Johnson, AP/Minneapolis Star Tribune, 5/28).
News of the day
Four Out Of Ten Skin Disease Sufferers Bullied
A shocking four out of every ten people who suffer from a skin disease in the UK have been bullied as a result of their condition, a new snapshot survey reveals.
Cardiovascular

Antibody Linked To Chemotherapy Drug Inhibits Ovarian Cancer In Lab

A novel anticancer agent, consisting of a monoclonal antibody linked to a chemotherapy drug, showed substantial antitumor activity in ovarian cancer cell lines and in mice, according to a study published online July 29 in the Journal of the National Cancer Institute. The agent, known as an immunoconjugate, targets a protein, EphA2, which is overexpressed in many human cancers but is absent or expressed at low levels in normal tissues. Anil K. Sood, M.D., of The University of Texas M.D. Anderson Cancer Center in Houston, and colleagues tested the immunoconjugate in ovarian cancer cell lines, where it bound to cells with high levels of EphA2 but not to those without the protein. In mice, the EphA2 immunoconjugate inhibited tumor growth by 85% compared with that in mice treated with a control immunoconjugate, a highly statistically significant difference. In cell lines, its antitumor effects were also statistically significantly related to decreased proliferation and increased apoptosis of tumor cells. Chemotherapy drugs typically affect both tumor and normal tissues, which can result in side effects. The immunoconjugate tested by the in this study allows for highly selective delivery of chemotherapy. "In summary," the authors write, "the findings herein provide a novel EphA2-targeted immunoconjugate with potent antitumor activity in ovarian carcinoma. Further preclinical and clinical developmentò€¦appears to be warranted." Steve Graff Journal of the National Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009